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Measurement of Atrial Refractoriness
Dispersion: Is There a Better Way?*
The electrographic characteristic of atrial fibrillation and its correla-
tion with atrial refractoriness have been investigated recently by Li et
al. (1). This study, in my view, has indeed provided some useful
information to our current knowledge of the mechanism of atrial
fibrillation that has puzzled many investigators for years. In this article
(1), the duration of atrial fibrillation was found to correlate moderately
well with the atrial effective refractory period in the right posterior
lateral wall in a canine atrial fibrillation model established by rapid
atrial pacing. However, no significant relation between the duration of
the fibrillation and the dispersion of effective refractoriness was
documented. This result is obviously, as the authors point out (1), in
conflict with the study by Wang et al. (2) in which atrial refractoriness
dispersion was found to be the only predictor of duration of atrial
fibrillation. Also in conflict with the report by Li et al. is another study
in humans (3) in which increased atrial refractoriness dispersion was
responsible for the recurrence of atrial fibrillation. Li et al. (1)
assumed that their result differed with regard to the association of
fibrillation duration and local refractoriness dispersion because of the
different animal models that they used or because of some other
essentially unknown reasons. However, I suggest that the disparity
between their results and those of the other two studies may be largely
attributed to the technique they used to measure atrial refractoriness
and its dispersion.
The classical method for the measurement of atrial refractoriness,
as used by Li et al. (1), is to introduce an extrastimulus in progressively
shorter coupling intervals until the extrastimulus fails to generate an
atrial response. The major limitation of this technique is its inability to
detect the local refractoriness in multiple atrial sites simultaneously.
This technical drawback may have limited its role in the assessment of
the dispersion of atrial refractoriness. As an alternative, averaged local
fibrillation intervals have been used as an index for local refractoriness
(4), based on the assumption that during the fibrillation, cells regain
their excitability as soon as their refractory period ends. The atrial
refractoriness measured in this way has been shown to correlate well
with the effective refractory period determined by the classical extra-
stimulus technique in both animals (4) and humans (3). Although the
averaged atrial fibrillation interval is not necessarily a true refractory
period, and it can only be regarded as a limit of refractoriness, it
indeed allows the assessment of refractory period at multiple sites
simultaneously. It should be appreciated that atrial fibrillation interval
as an index of local atrial refractoriness is still far from widespread
clinical use; however, its application in experimental studies of refrac-
toriness or refractoriness dispersion may need to be encouraged.
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